We have constructed a selectable Friend murine leukaemia virus (F-MuLV) with a suppressor tRNA (supF) gene integrated into the proviral long terminal repeat. The viral construct was infectious and pathogenic and retained the marker gene when growing in vitro or in vivo. Only a few integration sites of the provirus were detected by Southern blot analysis of the DNA of erythroleukaemic cells. These results indicate that F-MuLV-induced erythroleukaemia is of clonal origin and suggest that insertional mutagenesis is involved in pathogenesis.
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SUMMARY
We have constructed a selectable Friend murine leukaemia virus (F-MuLV) with a suppressor tRNA (supF) gene integrated into the proviral long terminal repeat. The viral construct was infectious and pathogenic and retained the marker gene when growing in vitro or in vivo. Only a few integration sites of the provirus were detected by Southern blot analysis of the DNA of erythroleukaemic cells. These results indicate that F-MuLV-induced erythroleukaemia is of clonal origin and suggest that insertional mutagenesis is involved in pathogenesis.
Retroviruses that do not harbour oncogenes within their genomes are assumed to induce oncogenic transformation by activating cellular genes following proviral insertion. Insertional mutagenesis has been described in various virus-induced tumours in birds and mammals involving known cellular proto-oncogenes such as c-myc, c-erbB or c-myb (see Bishop, 1987) or unknown oncogenes as int-1 and int-2 in mouse mammary tumour virus (MMTV)-induced mammary carcinomas (Papkoff et al., 1987; Dickson & Peters, 1987) or pim-1 in Moloney murine leukaemia virus (M-MuLV)-induced T-cell lymphomas (Selten et al., 1986) . Friend murine leukaemia virus (F-MuLV) is an ecotropic, helper-independent retrovirus, which induces erythroleukaemia in newborn BALB/c mice (Oliff et al., 1980) . In F-MuLV-induced erythroleukaemias, no insertional mutagenesis involving these or other genes has thus far been demonstrated.
The search for possible common integration sites in mice is hampered by the existence of numerous F-MuLV-related endogenous sequences within the mouse genome and by the appearance of recombinant murine mink cell focus-forming (MCF) viruses during tumour development. In addition, erythroleukaemias induced by F-MuLV are assumed to be of oligoclonal or even polyclonal origin due to the relatively short latency period of tumour development. Erythroleukaemic cell lines could only occasionally be established from F-MuLVinduced tumours (Shibuya & Mak, 1982) . To examine whether the disease caused by F-MuLV is of clonal origin and whether insertional mutagenesis is involved in the leukaemic process, we constructed a selectable F-MuLV harbouring a bacterial marker gene.
pF-MuLV57 is a genomic clone containing a single long terminal repeat (LTR) and two copies of the plasmid vector pBR322 (Koch et al., 1983) . To obtain higher yields of DNA on plasmid preparation, proviral DNA was separated from the vector and subcloned into the EcoRI site of pA327 (pA327 is a derivative of pBR327, which had been constructed for purposes not relevant here). The resulting plasmid pF-MuLV57-A has a unique recognition site for the enzyme EspI within the proviral LTR, 26 bp downstream of the 5' border of the U3 region, pUC9 ~p (a gift from K. Harbers, Hamburg, F.R.G.) contains a bacterial amber suppressor tRNA (supF) gene (Seed, 1983) , cloned within the EcoRI site of pUC9. Transformation of Escherichia coli (MC1061) and plasmid preparation were done by standard methods (Maniatis et al., 1982) .
Transfections of Rat-I fibroblasts with proviral DNA were performed by a calcium phosphate precipitation method (Stuhlmann et al., 1981) . Two weeks after transfection, supernatants of transfected cells were analysed by reverse transcriptase assays. Reverse transcriptase-positive cells were cloned by limiting dilution. For the reverse transcriptase assay, test material was incubated for 1 h at 37 °C in 60 m~,l-Tris-HC1 pH 8.2, 20 mM-KCI, 1 mMMnC12, 0.2~ 2-mercaptoethanol, 0.1 ~ Triton X-100, 5 ktg/ml poly(A)'oligo(dT)12_18, 5 ~tM-dTTP and 0.185 MBq [3H]dTTP; nucleic acids were precipitated in perchloric acid and filtered on Whatman GF/C filters. For determination of virus titres, Rat-1 cells were infected with dilutions of virus-containing medium and, after a 2 week incubation, cellular supernatants were tested for virus production by the reverse transcriptase assay.
For dot blot analysis of viral RNA, viruses were pelleted by centrifugation and RNA was extracted with phenol--chloroform. Dilutions of resuspended RNA were transferred to nitrocellulose and hybridized with random primer-labelled probes following the instructions of the suppliers of the slot blot apparatus (Schleicher & Schuell 'Minifold'). Filters were washed at a final stringency of 2 × SSPE (SSPE is 180 mM-NaC1, 10 mM-NazPO¢ pH 7-4, 1 mM-EDTA pH 7.4), 0.1~ SDS at 65 °C, and exposed to X-ray film.
For tumour induction, BALB/c mice less than 48 h old were inoculated intraperitoneally with 50 to 100 ~tl of cellular supernatant containing 105 to 107 infectious dose units (IDso) as measured by a virus dilution assay. Mice were checked for enlargement of spleen and liver under ether anaesthesia at 2 week intervals. For determination of haematocrit values, blood samples were taken from tail v~eins. Haematocrit values were expressed as a percentage of the blood volume. When the animals developed severe disease, they were sacrificed. Spleen, liver, lymph nodes and thymus were examined by gross pathology, and weights of spleen and liver were measured. Cytological staining of spleen and liver cells with Giemsa stain and, in some cases, with Sudan black, and peroxidase staining was performed using standard methods.
High Mr DNA was prepared from enlarged spleens following the protocol of Kaiser & Murray (1985) . Five to 10 ~tg of DNA from each tumour was digested, separated on 0.7~ agarose gels and transferred to 'Nytran' membrane (Schleicher & Schuell) by alkaline transfer in 0.4 M-NaOH, 0.6 M-NaC1. Following the instructions of the suppliers of the membranes, filters were hybridized with random primer-labelled probes, washed at a final stringency of 0.2 x SSPE, 0"5~o SDS at 65 °C, and exposed to X-ray film. Reik et al. (1985) and Lobel et al. (1985) have described the construction of selectable M-MuLVs bearing a bacterial suppressor tRNA (supF) gene stably integrated within the U3 region of the LTRs. Following their proposal, we inserted the supF gene of plasmid pUC9 ~p into the LTR of a derivative of pF-MuLV clone 57 (pF-MuLV57-A, see above; Fig. 1 ). The supF gene was isolated from pUC9 ~up by EcoRI digestion, agarose gel electrophoresis and electroelution, pF-MuLV57-A was digested with EspI. The protruding ends of both DNA fragments were made blunt by polymerase reaction and ligated by T4 ligase. After transformation of MC1061 cells several clones that contained the supF gene integrated within the proviral DNA were obtained. In clone pF-MULV ~up the supF gene was integrated in the proviral genome in a transcriptional orientation opposite to that of the viral sequences as tested by restriction analysis (data not shown). Proviral DNA of pF-MuLV ~p was isolated and ligated to itself (Fig. 1) .
To obtain infectious viral particles, concatenated pF-MuLV ~'p DNA was transfected into mammalian cells (Rat-1 fibroblasts). Cell clone FS-145 obtained by limiting dilution of transfected cells showed high virus titres in reverse transcriptase assays (2 x 105 to 5 x 105 c.p.m.) and virus dilution assays (about 107 to 108 IDso/ml). The supernatant of clone FS-145 was tested for the presence of envelope and supF sequences by dot blot hybridization using an F-MuLV57,transfected cell line as a control. Viral RNA from both the F-MuLV57-and the F-MuLV~uP-transfected cell lines hybridized with a specific F-MuLV envelope probe ( 
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, whereas only the RNA of FS-145 hybridized with the supF gene taken as a probe (Fig. 2b) . The supF gene remained stably integrated in the viral genome during at least 30 passages (data not shown).
To induce erythroleukaemic tumours, about 100 p.1 of the supernatant of cell line FS-145 (corresponding 10 6 to 107 ID5o) was injected intraperitoneally into susceptible newborn mice (BALB/c). No or only slight anaemia was found 3 weeks after infection, but all eight F-MuLV supinfected mice that survived the weaning time showed a haematocrit value of less than 41 ~ after about 10 weeks and less than 35~ after 12 weeks. Fifty ~ of the animals were diseased after 16 weeks and all mice were dead after 37 weeks. Within 9 to 22 weeks after infection, 79~ (26/33) mice showed signs of malignancy and were sacrificed. All but one had spleen tumours (spleen weight 420 to 2300 mg) and hepatomegaly. Cytological examination of these mice confirmed the erythroblastic origin of the tumour cells. One mouse with only mild hepatosplenomegaly showed an enlargement of the thymus, indicating a lymphomyeloid origin of the tumour. Seven out of 33 mice survived for more than 22 weeks without signs of severe disease. Since mice resistant to early erythroleukaemia induction are known to develop myeloid and lymphoid rather than erythroblastic leukaemias (Shibuya & Mak, 1982 ) these mice were not chosen for molecular analysis.
To investigate integration patterns of Friend proviruses, high Mr DNA was prepared from enlarged spleens of erythroleukaemic mice. DNA was digested with SacI which cuts within the pol gene and the LTR of F-MuLV ~'p yielding a supF-containing internal restriction fragment of about 6-5 kb (Fig. 3a) . When the supF gene was used as a probe in Southern blots, this fragment was found in the DNA of all tumours examined, demonstrating that proviruses retained the supF gene after integration. No hybridization signal was detected in DNA from mock-infected BALB/c mice (data not shown). Four to l0 additional distinct fragments were detected with the supF probe in each tumour DNA (Fig. 3a) . Since SacI has no recognition site within the LTR 5' of the supF gene, these fragments arose from SacI sites within the cellular DNA and represent upstream virus-cell junction fragments of the integration site (Fig. 3 b) . Each tumour showed an individual pattern of junction fragments ranging from only five fragments of similar intensity (tumour 6; 12-week-old mouse) to about 10 bands of varying intensities (tumour 7 ; 14-week-old mouse). Similar results were obtained using different restriction enzymes (data not shown). This is consistent with a mono-or oligoclonal origin of the tumour cells and the integration of F-MuLV into only a few sites of the genome of each cell clone. In addition to the internal F-MuLV fragment, one common fragment of about 1.3 kb in length was detected in four tumours (tumours 1, 5, 6 and, with very low intensity, tumour 4; see lower arrow in Fig. 3a ). This fragment may represent either a common integration site or an internal fragment of an F-MCFV arising during tumour development [F-MCFV clone pFM54B contained an additional SacI site within its LTR yielding a fragment of about 1.3 kb (Koch et al., 1984) ]. Whether the supF gene is retained during recombination leading to MCF viruses remains to be investigated. One band of similar intensity to the internal band was detected in tumours 1, 4 and 6. Since the intensity of the internal band (upper arrow in Fig. 3 a) should be the sum of the intensities of the junction fragments, this band may represent an additional internal fragment rather than a junction fragment. Aberrant internal fragments may arise by rearrangements of viral sequences.
In this paper we describe the construction of a selectable F-MuLV, harbouring a bacterial suppressor tRNA gene, supF, inserted into the LTR of F-MuLV clone 57. Within 22 weeks of injection of the constructed virus into newborn BALB/c mice, 76~ of all animals developed tumours, pathologically and cytologically similar to erythroleukaemic tumours of mice infected with wild-type virus. The data in the literature concerning the leukaemogenicity of wild-type virus in BALB/c mice vary, ranging from a mortality of 100K within 15 weeks to an incidence of leukaemia of 50~ within 2 to 4 months (Chesebro et al., 1984; Silver & Fredrickson, 1983; Shibuya & Mak, 1982; Ruscetti et al., 1981) . These differences may be due to differences in infection techniques, BALB/c sublines, virus substrains and definitions of disease. Notwithstanding, the virulence of the constructed viruses seems to be slightly diminished in comparison to the wild-type virus due to the alteration of the LTR, as has been described for low virulence F-MuLV variants (Sitbon et al., 1986) . Whereas wild-type virus-infected mice developed severe anaemia 3 weeks after infection, the haematocrit valve of F-MuLVsuP-infected mice was quite normal at that time. Twelve weeks after infection however, they developed severe anaemia, consistent with the erythroleukaemic type of tumour, since no or only mild anaemia has been described in animals with myeloid or lymphoid tumours (Shibuya & Mak, 1982) , suggesting that the constructed virus retained the pathogenic properties of its parental virus. Since the supF gene is retained in the viral genome in vivo we were able to analyse integrated proviruses in genomic D N A of enlarged organs by Southern blot hybridization using the supF gene as a probe. Only a small number of distinct integrations were detected in all tumours as early as 9 weeks after infection. Therefore, we can conclude that the event leading to blocked erythropoiesis, known as erythroleukaemia, is of clonal origin. This is remarkable considering the short latency period of the disease and the inability of tumour cells to give rise to permanent cell lines (Shibuya & Mak, 1982) . Furthermore, the number of D N A restriction fragments 
